RNS
REGN icon

Robert N. Shapiro’s Regeneron Pharmaceuticals REGN Stock Holding History

Robert N. Shapiro’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2K Hold
5
– – ﹤0.01% 835
2014
Q3 		$2K Buy
+5
New +$1.68K ﹤0.01% 832
2013
Q4 		– Sell
-830
Closed -$260K – 870
2013
Q3 		$260K Hold
830
– – 0.05% 239
2013
Q2 		$187K Buy
+830
New +$193K 0.04% 268

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Robert N. Shapiro's REGN Position: Q4 2014 in Review

Robert N. Shapiro held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2014 at 5 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Robert N. Shapiro first reported a position in REGN in Q2 2013 and has held it in 4 quarters since. The position peaked at $260K in Q3 2013. 512 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

  • Robert N. Shapiro held 5 shares of Regeneron Pharmaceuticals worth $2K as of Q4 2014.
  • Robert N. Shapiro left its Regeneron Pharmaceuticals share count unchanged in Q4 2014.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #835 holding.
  • Robert N. Shapiro first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • Robert N. Shapiro's Regeneron Pharmaceuticals position peaked at $260K in Q3 2013.
  • 512 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.